Načítá se...
Novel therapies for severe asthma in children and adults
The heterogeneous nature of asthma requires personalised treatments. Monoclonal antibody treatments showed good efficacy, and should be considered when symptoms are poorly controlled despite good inhaler technique, compliance and controlled comorbidities. http://ow.ly/UWpg30hImQh
Uloženo v:
| Vydáno v: | Breathe (Sheff) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
European Respiratory Society
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5831346/ https://ncbi.nlm.nih.gov/pubmed/29515670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.018917 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|